Russian Nootropic Stack Protocol - Semax + Selank

Russian Nootropic Stack Quick Reference

What Is the Russian Nootropic Stack?

The Russian Nootropic Stack is a two-peptide cognitive enhancement protocol combining Semax (ACTH(4-10) analogue) and Selank (tuftsin analogue) - two heptapeptides developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. This stack represents a dual-pathway cognitive model: neurotrophic stimulation and dopaminergic drive from Semax paired with GABAergic anxiolysis and serotonergic stabilization from Selank. The combination is designed to produce focused, clear cognition without the anxiety, overstimulation, or emotional blunting associated with single-mechanism nootropics or stimulant medications. Both compounds are registered pharmaceutical products in Russia with decades of clinical use.

Unlike single-peptide approaches where users must choose between cognitive enhancement (Semax alone) or anxiety reduction (Selank alone), the Russian Nootropic Stack addresses both simultaneously. The rationale is rooted in the common clinical observation that anxiety impairs cognitive performance and that cognitive stimulation without emotional regulation produces an incomplete response. By targeting both the "gas" (Semax: BDNF, dopamine, focus) and the "brakes" (Selank: GABA, serotonin, calm), the stack aims to produce a state frequently described in the community as "calm focus" - sustained attention and mental clarity under pressure without jitteriness, emotional reactivity, or post-use crashes.

No direct clinical trial has evaluated the full 2-peptide Semax + Selank combination. Combined protocols are extrapolated from individual compound evidence, Russian clinical practice where both compounds have been prescribed concurrently, and practitioner/community usage patterns. An fMRI study (Bakhmet et al., 2020) examined both Semax and Selank in the same healthy volunteer cohort and identified both shared and distinct effects on amygdala-temporal cortex functional connectivity, providing indirect neuroimaging support for complementary mechanisms.

Why Combine Semax and Selank?

Two complementary Russian neuropeptides, two distinct receptor systems

Semax and Selank were developed by overlapping research teams at the same Russian institution and were designed from the outset to address different facets of CNS function. Semax provides the neurotrophic and activating foundation - upregulating BDNF and NGF, enhancing dopaminergic and serotonergic drive, and protecting neurons from oxidative and ischemic damage. Selank provides the regulatory and calming complement - modulating GABAergic tone, stabilizing serotonin metabolism, inhibiting enkephalin degradation, and reducing anxiety without cognitive impairment. Combining them creates a stacked neurochemical environment where cognitive capacity is enhanced while the emotional system is simultaneously stabilized.

Neurotrophic Amplification (BDNF/NGF x GABA Priming)

Semax is one of the most potent known BDNF-elevating peptides, rapidly increasing brain-derived neurotrophic factor and nerve growth factor expression in the hippocampus and frontal cortex. BDNF drives synaptic plasticity, memory consolidation, and learning capacity. Selank contributes to this pathway by creating a calmer baseline neurochemical environment - reduced GABAergic anxiety tone allows BDNF-driven neuroplasticity to operate more effectively. Anxiety and chronic stress suppress BDNF expression; Selank's anxiolytic effects may therefore remove a brake on Semax's neurotrophic activity, producing a synergistic rather than merely additive cognitive enhancement.

Balanced Neurotransmitter Modulation (Dopamine Drive + GABA Regulation)

Semax activates dopaminergic and serotonergic pathways, enhancing attention, motivation, executive function, and processing speed. However, dopaminergic activation without adequate inhibitory counterbalance can produce overstimulation, irritability, or anxious arousal - side effects occasionally reported with Semax alone, especially at higher doses. Selank's GABAergic modulation provides precisely this counterbalance: it enhances inhibitory neurotransmission in a manner comparable to benzodiazepines but without sedation, tolerance, or cognitive impairment. This creates a "focused calm" where dopaminergic sharpness is expressed without the edge of overstimulation.

Stress Resilience and Emotional Regulation

Both compounds independently demonstrate stress-modulating effects, but through different mechanisms. Semax attenuates stress-related behavioral changes through neurotrophic support and anti-inflammatory transcriptomic modulation (suppressing pro-inflammatory gene expression under ischemic/stress conditions). Selank attenuates stress through GABAergic anxiolysis and enkephalin stabilization - directly dampening the physiological anxiety response. Combined, the stack provides multi-layered stress resilience: neuroprotection from stress-related damage (Semax) plus real-time emotional dampening of the stress response itself (Selank). This is particularly relevant for sustained high-performance cognitive demands - exam preparation, executive decision-making, creative output under deadline pressure.

Immunomodulatory Convergence

Both Semax and Selank exhibit immunomodulatory properties, though through different pathways. Semax modulates chemokine and immunoglobulin gene expression and enhances vascular/immune responses during ischemia. Selank modulates IL-6 and Th1/Th2 cytokine balance with demonstrated immunomodulatory effects in human anxiety patients. The convergence of these immune pathways provides a secondary adaptogenic benefit, potentially supporting immune resilience during periods of high cognitive and physical stress - a common concern for the biohacking/performance audience.

Russian Nootropic Stack Dosing Protocol & Schedule

Format A: Separate Vials (Subcutaneous Injection)

Format B: Intranasal Protocol

Intranasal spacing: Administer Selank first, wait 15-30 minutes, then administer Semax. This spacing ensures independent absorption and allows assessment of Selank's calming baseline before adding Semax's activating effects.

Protocol Notes

• Injection logistics: Semax and Selank may be administered as two separate subcutaneous injections at different sites during the same morning session. Use separate syringes. Do not mix the two peptides in the same syringe.
• Morning administration is essential: Semax promotes wakefulness and dopaminergic activity. All Semax doses must be administered before 2 PM to avoid sleep interference. Selank is non-sedating and can technically be given at any time, but morning co-administration with Semax simplifies the protocol.
• Staggered introduction recommended: Community consensus strongly favors introducing one compound at a time. Start Selank alone for the first 5-7 days to assess individual response, then add Semax. This allows attribution of any side effects to the specific compound.
• Dose titration is independent: Titrate each compound independently based on individual response. Some users find optimal results at 300 mcg Semax + 250 mcg Selank; others require 800 mcg Semax + 500 mcg Selank. The dose ratio is not fixed.
• Hydration: Both compounds may subtly affect water balance. Adequate hydration (2-3 L/day) is recommended, particularly to prevent headache - the most commonly reported stack side effect.
• Stimulant caution: Users taking stimulant medications (Adderall, Ritalin, modafinil) should exercise caution when adding Semax, as dopaminergic effects may be additive. MAO inhibitors should be avoided. Selank's GABAergic profile does not carry the same stimulant-interaction risk.

Russian Nootropic Stack Reconstitution Guide

Format A: Separate Vials

Math Verification

• Semax 10 mg / 3 mL = 10,000 mcg / 3 mL = 3,333 mcg/mL -> 600 mcg / 3,333 = 0.18 mL -> 0.18 x 100 = 18 units.
• Selank 10 mg / 3 mL = 10,000 mcg / 3 mL = 3,333 mcg/mL -> 400 mcg / 3,333 = 0.12 mL -> 0.12 x 100 = 12 units.
• Semax 5 mg / 2 mL = 5,000 mcg / 2 mL = 2,500 mcg/mL -> 500 mcg / 2,500 = 0.20 mL -> 0.20 x 100 = 20 units.
• Selank 5 mg / 2 mL = 5,000 mcg / 2 mL = 2,500 mcg/mL -> 250 mcg / 2,500 = 0.10 mL -> 0.10 x 100 = 10 units.

Limiting factor: Semax's light sensitivity makes it the more storage-sensitive compound. Store both vials refrigerated, light-protected, and use within 30 days of reconstitution.

Standard 7-Step Reconstitution (Perform Separately for Each Compound)

1. Gather supplies: Two separate lyophilized vials (Semax + Selank), bacteriostatic water, two sterile insulin syringes, alcohol swabs, sharps container, foil for light protection.
2. Clean vials: Wipe the rubber septum of each peptide vial and the BAC water vial with separate alcohol swabs. Allow to air dry.
3. Draw BAC water: Using a fresh sterile syringe for each vial, draw the target volume of bacteriostatic water (2 mL or 3 mL per the table above).
4. Inject slowly: Insert the needle and inject BAC water gently along the inner wall of each vial. Avoid directing the stream at the lyophilized powder.
5. Allow to dissolve: Let each vial sit for 1-2 minutes. Do not shake vigorously.
6. Gently mix: Roll each vial gently between palms until powder is fully dissolved and solution is clear.
7. Label and store: Write compound name, reconstitution date, concentration, and discard-by date on each vial. Wrap Semax vial in foil. Refrigerate both at 2-8C immediately.

Russian Nootropic Stack Side Effects & Safety

Both Semax and Selank individually have favorable safety profiles supported by decades of Russian clinical use. Semax is listed on Russia's List of Vital & Essential Drugs. Selank's safety has been compared favorably to benzodiazepines in multiple clinical studies. However, no clinical trial has evaluated the combined Semax + Selank stack.

Combined/amplified concerns

• Overlapping monoaminergic modulation: Both compounds influence serotonin metabolism. While no published data reports serotonergic excess from the combination, users should monitor for signs of excessive serotonergic activity (agitation, restlessness, elevated heart rate) - particularly if also taking SSRIs, MAO inhibitors, or other serotonergic compounds.
• Additive dopaminergic stimulation: Semax activates dopaminergic pathways. While Selank's GABAergic effects typically counterbalance stimulatory effects, users sensitive to dopaminergic stimulation (or those already taking stimulant medications) should titrate cautiously and start at the low end of both dose ranges.
• Immunomodulatory convergence: Both compounds modulate immune system signaling (Semax via chemokine/immunoglobulin gene expression; Selank via IL-6 and Th1/Th2 balance). In immunocompromised individuals or those with autoimmune conditions, overlapping immune modulation warrants caution and medical oversight.
• Multi-source contamination risk: Sourcing two research-grade peptides from separate suppliers doubles the quality-control surface area. Both compounds should be sourced from Finnrick Analytics-tested or COA-verified suppliers. The FDA's immunogenicity concern for compounded Selank applies to the combination context as well.

Common community-reported side effects for the stack

• Mild headache (most common; usually resolves with hydration and occurs primarily in the first few days)
• Sleep disruption if Semax is dosed too late in the day
• Mild nasal irritation (intranasal route)
• Transient irritability or emotional sensitivity (usually dose-dependent and resolves with reduction)
• Injection site redness (subcutaneous route; resolves with site rotation)

Clinical Evidence Context

The Russian Nootropic Stack is a complementary-mechanism model: neurotrophic cognitive activation (Semax: BDNF/NGF, dopamine, neuroprotection) paired with inhibitory anxiolytic regulation (Selank: GABA, serotonin, enkephalin stabilization), together targeting both the capacity and the emotional environment for sustained cognitive performance.

Storage & Handling

Limiting factor: Semax's light sensitivity governs storage planning. Both vials should be stored refrigerated and light-protected for consistency. Use reconstituted solutions within 30 days. Avoid freeze-thaw cycles for both compounds.

Russian Nootropic Stack vs. Semax Alone vs. Semax + Selank + DSIP Triple Stack

Decision guidance

• Choose Semax alone when the primary goal is cognitive enhancement or neuroprotection and anxiety is not a concern.
• Choose the Russian Nootropic Stack (Semax + Selank) when cognitive demands are high AND anxiety, stress, or emotional reactivity impair performance - the most common scenario for executives, students, and professionals under chronic pressure.
• Choose the Triple Stack (Semax + Selank + DSIP) when sleep quality is also compromised, as poor sleep undermines both cognitive enhancement and anxiety management.

Related Stacking Protocols

Semax + Selank + DSIP Triple Nootropic Stack

A three-compound extension of the Russian Nootropic Stack that adds Delta Sleep-Inducing Peptide (DSIP) for sleep architecture optimization. DSIP is administered at bedtime and is designed to enhance deep/restorative sleep, supporting the memory consolidation and neuroplasticity processes that Semax and Selank promote during waking hours. Commonly offered as a clinical blend at peptide therapy clinics.

Link: `/stacks/semax-selank-dsip-stack` (if/when created)

Semax + Selank + Cerebrolysin Advanced Neurostack

An advanced three-compound neuroprotection stack adding Cerebrolysin - a porcine brain-derived peptide preparation - for maximum neurotrophic coverage. Cerebrolysin provides a mixture of peptide fragments that mimic endogenous growth factors, creating an amplified neurotrophic environment alongside Semax's BDNF upregulation and Selank's anxiolytic support. This stack is discussed in advanced clinical nootropic literature but involves significantly greater complexity and cost.

No current PDP page. Consider for future development.

Selank + BPC-157 Gut-Brain Anxiolytic Stack

A combination targeting the gut-brain axis, pairing Selank's CNS anxiolysis with BPC-157's gut-healing and cytoprotective effects. This stack is sometimes used by individuals whose anxiety has a gastrointestinal component (for example IBS comorbidity, gut inflammation-driven mood disturbance). See the BPC-157 Protocol Page for component details.

No current PDP stack page.

Frequently Asked Questions - Russian Nootropic Stack

Sources & Research

1. Gusev EI, et al. "The efficacy of semax in the treatment of patients at different stages of ischemic stroke." Zh Nevrol Psikhiatr Im S S Korsakova, 2018 Link.
2. Zozulia AA, et al. "Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia." Zh Nevrol Psikhiatr Im S S Korsakova, 2008 Link.
3. Seredenin SB, et al. "A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders." Zh Nevrol Psikhiatr Im S S Korsakova, 2014 Link.
4. Bakhmet AA, et al. "Functional Connectomic Approach to Studying Selank and Semax Effects." Bull Exp Biol Med, 2020 Link.
5. Medvedeva EV, et al. "The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis." BMC Genomics, 2014 Link.
6. Volkova A, et al. "Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission." Frontiers in Pharmacology, 2016 Link.
7. Filatova E, et al. "GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells." Frontiers in Pharmacology, 2017 Link.
8. Kasian A, et al. "Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats." BioMed Research International, 2017 Link.
9. Dergunova LV, et al. "Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats." Genes (MDPI), 2020 Link.
10. Kolomin T, et al. "A New Generation of Drugs: Synthetic Peptides Based on Natural Regulatory Peptides." Neuroscience & Medicine, 2013 Link.
11. Uchakina ON, et al. "Immunomodulatory effects of selank in patients with anxiety-asthenic disorders." Bull Exp Biol Med, 2008 Link.
12. Wikipedia "Semax." Reference, n.d. Link.

Related Protocols

Disclaimer